Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: A multicenter prospective study

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 194-201

  Yasumoto, Kosei ^a   Osaki, Toshihiro ^b   Watanabe, Yoh ^b   Kato, Harubumi ^b   Yoshimura, Takesumi ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKERATIN; CYTOKERATIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CELL SURVIVAL; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG HILUS; LUNG NON SMALL CELL CANCER; LYMPH NODE CELL; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL TIME;

ADULT; AGED; BIOPSY, NEEDLE; BONE MARROW; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KERATINS; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0038676362     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00130-9     Document Type: Article

References (25)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
2. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
3. Ohgami A, Mitsudomi T, Yasumoto K, et al. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg 1997;64:363-7.
4. Pantel K, Izbicki JR, Angstwurm M, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell cancer. Cancer Res 1993;53:1027-31.
5. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347:649-53.
6. Cote RJ, Beattie EJ, Chaiwun B, et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 1995;222:415-25.
7. Chen ZL, Perez S, Holmes EC, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:493-8.
8. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996;61: 177-83.
9. Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997; 114:535-43.
10. Hashimoto T, Kobayashi Y, Ishikawa Y, et al. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res 2000;60: 6472-8.
11. Wu J, Ohta Y, Minato H, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 2001;71:1772-8.
12. Dingemans AM, Brakenhoff RH, Postmus PE, Giaccone G. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest 1997;77:213-20.
13. Krismann M, Todt B, Schroder J, et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995;13:2769-75.
14. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
15. Osaki T, Oyama T, Yasumoto K, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small cell lung cancer. J Clin Oncol 2002;20:2930-6.
16. Pantel K, Schlimok G, Braun S, et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993;85:1419-24.
17. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
18. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow, and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33.
19. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340: 685-9.
20. Thorban S, Roder JD, Nekarda H, Funk A, Siewert JR, Pantel K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J Natl Cancer Inst 1996;88:1222-7.
21. Traweek ST, Liu J, Battifora H. Keratin gene expression in nonepithelial tissues: detection with polymerase chain reaction. Am J Pathol 1993;142:1111-8.
22. Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K. Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg 1997;114:339-46.
23. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multi-factorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994;57:1-9.
24. Brambilla E, Gazzeri S, Moro D, et al. Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol 1993;143:199-210.
25. Gu CD, Osaki T, Yasumoto K, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival. Ann Surg 2002;235:133-9.